Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 280816011000036112 | Fabrazyme (agalsidase beta 35 mg) powder for injection, 1 x 35 mg vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 280817011000036110 | Fabrazyme 35 mg powder for injection, 1 vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fabrazyme 35 mg powder for injection, 1 vial | has TP | Fabrazyme | true | Inferred relationship | Some | ||
| Fabrazyme 35 mg powder for injection, 1 vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Fabrazyme 35 mg powder for injection, 1 vial | Is a | Fabrazyme 35 mg powder for injection, 1 vial | true | Inferred relationship | Some | ||
| Fabrazyme 35 mg powder for injection, 1 vial | has container type | vial | true | Inferred relationship | Some | ||
| Fabrazyme 35 mg powder for injection, 1 vial | has TPUU | Fabrazyme 35 mg powder for injection, 35 mg vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR